{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:24:53Z","timestamp":1776119093944,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Pontificia Universidad Catolica de Chile"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bcp.2018.08.045","type":"journal-article","created":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T12:11:57Z","timestamp":1535803917000},"page":"357-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension"],"prefix":"10.1016","volume":"156","author":[{"given":"Leticia","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulises","family":"Novoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackeline","family":"Moya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge E.","family":"Jalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Chiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Lavandero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Paz","family":"Ocaranza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2018.08.045_b0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1253\/circj.CJ-18-0063","article-title":"Inflammatory mechanisms of cardiovascular remodeling","volume":"82","author":"Anzai","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.bcp.2018.08.045_b0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/157340310793566109","article-title":"The DOCA-salt hypertensive rat as a model of cardiovascular oxidative and inflammatory stress","volume":"6","author":"Iyer","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.bcp.2018.08.045_b0015","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2018.08.045_b0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/FJC.0b013e318064f150","article-title":"Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte\/macrophage infiltration in the heart of DOCA\/salt hypertensive rats","volume":"50","author":"Ishimaru","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bcp.2018.08.045_b0025","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2018.08.045_b0030","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/y05-068","article-title":"Hypertension CMRGo. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy","volume":"83","author":"Neves","year":"2005","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bcp.2018.08.045_b0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.CIR.103.2.319","article-title":"Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism","volume":"103","author":"Ammarguellat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2018.08.045_b0040","article-title":"Collecting duct renin does not mediate DOCA-salt hypertension or renal injury","volume":"11","author":"Song","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2018.08.045_b0045","doi-asserted-by":"crossref","first-page":"9793","DOI":"10.1038\/s41598-017-09470-0","article-title":"Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2018.08.045_b0050","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0895-7061(96)00119-7","article-title":"Respective role of humoral factors and blood pressure in aortic remodeling of DOCA hypertensive rats","volume":"9","author":"Karam","year":"1996","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bcp.2018.08.045_b0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1753944715597623","article-title":"ACE2 and vasoactive peptides: novel players in cardiovascular\/renal remodeling and hypertension","volume":"9","author":"Mendoza-Torres","year":"2015","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.bcp.2018.08.045_b0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/CS20130449","article-title":"Recent insights and therapeutic perspectives of angiotensin-(1\u20139) in the cardiovascular system","volume":"127","author":"Ocaranza","year":"2014","journal-title":"Clin. Sci. (Lond)."},{"key":"10.1016\/j.bcp.2018.08.045_b0065","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","article-title":"Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat","volume":"48","author":"Ocaranza","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2018.08.045_b0070","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/HJH.0b013e328335d291","article-title":"Angiotensin-(1\u20139) regulates cardiac hypertrophy in vivo and in vitro","volume":"28","author":"Ocaranza","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bcp.2018.08.045_b0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/HYPERTENSIONAHA.111.177485","article-title":"Angiotensin-(1\u20139) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor","volume":"59","author":"Flores-Munoz","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2018.08.045_b0080","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0002-9149(96)00425-0","article-title":"Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography","volume":"78","author":"de Simone","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bcp.2018.08.045_b0085","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/HJH.0000000000000094","article-title":"Angiotensin-(1\u20139) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme\/Ang II axis","volume":"32","author":"Ocaranza","year":"2014","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bcp.2018.08.045_b0090","doi-asserted-by":"crossref","DOI":"10.3791\/3119","article-title":"Mesenteric artery contraction and relaxation studies using automated wire myography","author":"Bridges","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bcp.2018.08.045_b0095","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/01.HYP.0000188980.57312.63","article-title":"Increased aortic NADPH oxidase activity in rats with genetically high angiotensin-converting enzyme levels","volume":"46","author":"Jalil","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2018.08.045_b0100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0021-9673(97)00583-9","article-title":"Analysis of nitrate in biological fluids by capillary electrophoresis","volume":"781","author":"Friedberg","year":"1997","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.bcp.2018.08.045_b0105","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/HJH.0b013e3283440665","article-title":"Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1\u20139) axis in experimental hypertension","volume":"29","author":"Ocaranza","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bcp.2018.08.045_b0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.RES.0000059987.90200.44","article-title":"Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle","volume":"92","author":"Seko","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2018.08.045_b0115","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/bph.13044","article-title":"Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis","volume":"172","author":"Bruce","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.08.045_b0120","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/01.HYP.0000017283.67962.02","article-title":"Angiotensin 1\u20139 and 1\u20137 release in human heart: role of cathepsin A","volume":"39","author":"Jackman","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2018.08.045_b0125","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/ATVBAHA.110.219238","article-title":"Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo","volume":"31","author":"Ray","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2018.08.045_b0130","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.lfs.2013.10.020","article-title":"Stimulation of ANP by angiotensin-(1\u20139) via the angiotensin type 2 receptor","volume":"93","author":"Cha","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2018.08.045_b0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.36.3.312","article-title":"Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants","volume":"36","author":"Intengan","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2018.08.045_b0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11906-016-0628-7","article-title":"Role of inflammation and immunity in hypertension: recent epidemiological, laboratory, and clinical evidence","volume":"18","author":"Caillon","year":"2016","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.bcp.2018.08.045_b0145","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11906-011-0224-9","article-title":"Immune mechanisms in hypertension","volume":"13","author":"Leibowitz","year":"2011","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.bcp.2018.08.045_b0150","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/585989","article-title":"Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives","volume":"2010","author":"Tkacova","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bcp.2018.08.045_b0155","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/ndt\/gfl019","article-title":"Inflammation and hypertension: the search for a link","volume":"21","author":"Pauletto","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bcp.2018.08.045_b0160","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/HYPERTENSIONAHA.111.187021","article-title":"Vascular remodeling in hypertension: mechanisms and treatment","volume":"59","author":"Schiffrin","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2018.08.045_b0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10557-017-6717-2","article-title":"Inhibition of the renin-angiotensin system post myocardial infarction prevents inflammation-associated acute cardiac rupture","volume":"31","author":"Gao","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.bcp.2018.08.045_b0170","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1210\/endo.142.8.8339","article-title":"Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration","volume":"142","author":"Fujisawa","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2018.08.045_b0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0065-2776(05)89006-6","article-title":"Regulation of fibrosis by the immune system","volume":"89","author":"Lupher","year":"2006","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.bcp.2018.08.045_b0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/excr.2000.4869","article-title":"Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast","volume":"257","author":"Vaughan","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2018.08.045_b0185","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bcp.2018.08.045_b0190","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2018.08.045_b0195","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/00004872-200405000-00024","article-title":"Tranilast attenuates myocardial fibrosis in association with suppression of monocyte\/macrophage infiltration in DOCA\/salt hypertensive rats","volume":"22","author":"Kagitani","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bcp.2018.08.045_b0200","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/HYPERTENSIONAHA.112.203158","article-title":"Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone\/salt-mediated inflammation and cardiac fibrosis","volume":"60","author":"Rickard","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2018.08.045_b0205","first-page":"2468","article-title":"Correlation between platelet-derived growth factor signaling pathway and inflammation in desoxycorticosterone-induced salt-sensitive hypertensive rats with myocardial fibrosis","volume":"6","author":"Fan","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bcp.2018.08.045_b0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/fca.12.75","article-title":"Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system","volume":"9","author":"Clarke","year":"2013","journal-title":"Future Cardiol."},{"key":"10.1016\/j.bcp.2018.08.045_b0215","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ki.2013.193","article-title":"Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats","volume":"84","author":"Ali","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2018.08.045_b0220","doi-asserted-by":"crossref","first-page":"F1189","DOI":"10.1152\/ajprenal.00377.2013","article-title":"Angiotensin II AT2 receptor activation attenuates AT1 receptor-induced increases in the glomerular filtration of albumin: a multiphoton microscopy study","volume":"305","author":"Schiessl","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bcp.2018.08.045_b0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","article-title":"ACE2, angiotensin-(1\u20137), and Mas: the other side of the coin","volume":"465","author":"Bader","year":"2013","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bcp.2018.08.045_b0230","first-page":"532","article-title":"La progresi\u00f3n de la enfermedad renal: Una revisi\u00f3n","volume":"5","author":"Rond\u00f3n","year":"1999","journal-title":"Med-ULA"},{"key":"10.1016\/j.bcp.2018.08.045_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","article-title":"Tubulointerstitial changes as a major determinant in the progression of renal damage","volume":"20","author":"Nath","year":"1992","journal-title":"Am. J. Kidney Dis."},{"issue":"Suppl 4","key":"10.1016\/j.bcp.2018.08.045_b0240","first-page":"36","article-title":"Genetic variation and progression of renal failure","volume":"23","author":"Gonzalez","year":"2003","journal-title":"Nefrologia"},{"issue":"Suppl 5","key":"10.1016\/j.bcp.2018.08.045_b0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ndt\/16.suppl_5.3","article-title":"The role of macrophages in glomerulonephritis","volume":"16","author":"Nikolic-Paterson","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bcp.2018.08.045_b0250","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/ndt\/gfg313","article-title":"Macrophage heterogeneity in renal inflammation","volume":"18","author":"Erwig","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bcp.2018.08.045_b0255","first-page":"338","article-title":"Chronic kidney disease: classification, mechanisms of progression and strategies for renoprotection","volume":"133","author":"Mezzano","year":"2005","journal-title":"Rev. Med. Chil."},{"key":"10.1016\/j.bcp.2018.08.045_b0260","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/hy09t1.094234","article-title":"Angiotensin II and renal fibrosis","volume":"38","author":"Mezzano","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2018.08.045_b0265","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bcp.2015.03.009","article-title":"Treatment with angiotensin-(1\u20139) alleviates the cardiomyopathy in streptozotocin-induced diabetic rats","volume":"95","author":"Zheng","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.08.045_b0270","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1113\/jphysiol.2010.203075","article-title":"Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor","volume":"589","author":"Flores-Munoz","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2018.08.045_b0275","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/01.HYP.0000090323.58122.5C","article-title":"Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice","volume":"42","author":"Abadir","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2018.08.045_b0280","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.HYP.0000176744.15592.7d","article-title":"Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries","volume":"46","author":"Brassard","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2018.08.045_b0285","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbrc.2007.11.061","article-title":"Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque","volume":"366","author":"Dandapat","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2018.08.045_b0290","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.atherosclerosis.2007.11.006","article-title":"Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression","volume":"199","author":"Hu","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bcp.2018.08.045_b0295","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.hjh.0000166845.49850.39","article-title":"Negative regulation of RhoA\/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats","volume":"23","author":"Savoia","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bcp.2018.08.045_b0300","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/01.HYP.37.2.301","article-title":"Angiotensin II relaxes microvessels via the AT(2) receptor and Ca(2+)-activated K(+) (BK(Ca)) channels","volume":"37","author":"Dimitropoulou","year":"2001","journal-title":"Hypertension"},{"issue":"Pt 2","key":"10.1016\/j.bcp.2018.08.045_b0305","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/bj3250449","article-title":"Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase","volume":"325","author":"Bedecs","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2018.08.045_b0310","doi-asserted-by":"crossref","first-page":"19022","DOI":"10.1074\/jbc.272.30.19022","article-title":"Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis","volume":"272","author":"Horiuchi","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.08.045_b0315","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/CCM.0b013e3181bc8293","article-title":"Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry","volume":"38","author":"Rajagopal","year":"2010","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bcp.2018.08.045_b0320","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine: a novel component of the renin-angiotensin system","volume":"112","author":"Lautner","year":"2013","journal-title":"Circ. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218303812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218303812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T20:22:29Z","timestamp":1539289349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218303812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":64,"alternative-id":["S0006295218303812"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.08.045","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.08.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}